SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

AEON Biopharma Expects $6.2 Million From Warrant Exercises

Valid market news retained in the public archive without immediate LiveCast distribution.

AEON

Story updates

01:53:20 PM UTC
SquawkNews
AEON Biopharma entered into an amendment with holders of its two-year milestone warrants, reducing the exercise price for common shares to $0.20 per share and for pre-funded warrants to $0.1999 each. Certain participating holders agreed to exercise their warrants at the reduced prices, and the comp…

Related stories